» Articles » PMID: 32046082

Targeting Bacterial Cell Division: A Binding Site-Centered Approach to the Most Promising Inhibitors of the Essential Protein FtsZ

Overview
Specialty Pharmacology
Date 2020 Feb 13
PMID 32046082
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Binary fission is the most common mode of bacterial cell division and is mediated by a multiprotein complex denominated the divisome. The constriction of the Z-ring splits the mother bacterial cell into two daughter cells of the same size The Z-ring is formed by the polymerization of FtsZ, a bacterial protein homologue of eukaryotic tubulin, and it represents the first step of bacterial cytokinesis. The high grade of conservation of FtsZ in most prokaryotic organisms and its relevance in orchestrating the whole division system make this protein a fascinating target in antibiotic research. Indeed, FtsZ inhibition results in the complete blockage of the division system and, consequently, in a bacteriostatic or a bactericidal effect. Since many papers and reviews already discussed the physiology of FtsZ and its auxiliary proteins, as well as the molecular mechanisms in which they are involved, here, we focus on the discussion of the most compelling FtsZ inhibitors, classified by their main protein binding sites and following a medicinal chemistry approach.

Citing Articles

Targeting Bacterial Cell Division with Benzodioxane-Benzamide FtsZ Inhibitors as a Novel Strategy to Fight Gram-Positive Ovococcal Pathogens.

Furlan B, Sobrinos-Sanguino M, Sammartino M, Monterroso B, Zorrilla S, Lanzini A Int J Mol Sci. 2025; 26(2).

PMID: 39859428 PMC: 11765573. DOI: 10.3390/ijms26020714.


Computational docking of FtsZ: Survey of promising antibiotic compounds.

Espino I, Drolet J, Jones T, Uwechue A, Koehler B, Beaird R Biochem Biophys Rep. 2024; 39:101796.

PMID: 39687410 PMC: 11647940. DOI: 10.1016/j.bbrep.2024.101796.


Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research.

Sussmuth R, Sussmuth R, Kulike-Koczula M, Kulike-Koczula M, Gao P, Kosol S Angew Chem Int Ed Engl. 2024; 64(10):e202414325.

PMID: 39611429 PMC: 11878372. DOI: 10.1002/anie.202414325.


Isatin Bis-Imidathiazole Hybrids Identified as FtsZ Inhibitors with On-Target Activity Against .

Morigi R, Esposito D, Calvaresi M, Marforio T, Gentilomi G, Bonvicini F Antibiotics (Basel). 2024; 13(10).

PMID: 39452258 PMC: 11505029. DOI: 10.3390/antibiotics13100992.


Promising New Targets for the Treatment of Infections Caused by : A Review.

Borges K, Kipnis A, Neves B, Junqueira-Kipnis A Curr Drug Targets. 2024; 25(14):971-986.

PMID: 39225221 DOI: 10.2174/0113894501319269240819060245.


References
1.
Lui H, Gao W, Cheung K, Jin W, Sun N, Kan J . Boosting the efficacy of anti-MRSA β-lactam antibiotics via an easily accessible, non-cytotoxic and orally bioavailable FtsZ inhibitor. Eur J Med Chem. 2018; 163:95-115. DOI: 10.1016/j.ejmech.2018.11.052. View

2.
Chiodini G, Pallavicini M, Zanotto C, Bissa M, Radaelli A, Straniero V . Benzodioxane-benzamides as new bacterial cell division inhibitors. Eur J Med Chem. 2014; 89:252-65. DOI: 10.1016/j.ejmech.2014.09.100. View

3.
Bi F, Song D, Qin Y, Liu X, Teng Y, Zhang N . Discovery of 1,3,4-oxadiazol-2-one-containing benzamide derivatives targeting FtsZ as highly potent agents of killing a variety of MDR bacteria strains. Bioorg Med Chem. 2019; 27(14):3179-3193. DOI: 10.1016/j.bmc.2019.06.010. View

4.
Faguy D, Doolittle W . Cytoskeletal proteins: the evolution of cell division. Curr Biol. 1998; 8(10):R338-41. DOI: 10.1016/s0960-9822(98)70216-7. View

5.
Straniero V, Zanotto C, Straniero L, Casiraghi A, Duga S, Radaelli A . 2,6-Difluorobenzamide Inhibitors of Bacterial Cell Division Protein FtsZ: Design, Synthesis, and Structure-Activity Relationships. ChemMedChem. 2017; 12(16):1303-1318. DOI: 10.1002/cmdc.201700201. View